NZ504503A - Oxazolidinone derivatives and pharmaceutical use as antimicrobial agents - Google Patents

Oxazolidinone derivatives and pharmaceutical use as antimicrobial agents

Info

Publication number
NZ504503A
NZ504503A NZ504503A NZ50450398A NZ504503A NZ 504503 A NZ504503 A NZ 504503A NZ 504503 A NZ504503 A NZ 504503A NZ 50450398 A NZ50450398 A NZ 50450398A NZ 504503 A NZ504503 A NZ 504503A
Authority
NZ
New Zealand
Prior art keywords
antimicrobial agents
pharmaceutical use
oxazolidinone derivatives
organisms
oxazolidinone
Prior art date
Application number
NZ504503A
Other languages
English (en)
Inventor
Jackson B Hester
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NZ504503A publication Critical patent/NZ504503A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ504503A 1997-11-12 1998-10-30 Oxazolidinone derivatives and pharmaceutical use as antimicrobial agents NZ504503A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6537697P 1997-11-12 1997-11-12
PCT/US1998/022639 WO1999024428A1 (en) 1997-11-12 1998-10-30 Oxazolidinone derivatives and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
NZ504503A true NZ504503A (en) 2002-10-25

Family

ID=22062294

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ504503A NZ504503A (en) 1997-11-12 1998-10-30 Oxazolidinone derivatives and pharmaceutical use as antimicrobial agents

Country Status (21)

Country Link
US (1) US5998406A (enExample)
EP (1) EP1030852B1 (enExample)
JP (1) JP2001522849A (enExample)
KR (1) KR20010031953A (enExample)
CN (1) CN1154644C (enExample)
AT (1) ATE250054T1 (enExample)
AU (1) AU739055B2 (enExample)
BR (1) BR9813985A (enExample)
CA (1) CA2303959A1 (enExample)
DE (1) DE69818294T2 (enExample)
DK (1) DK1030852T3 (enExample)
ES (1) ES2207010T3 (enExample)
HU (1) HUP0100470A3 (enExample)
IL (1) IL136062A (enExample)
NO (1) NO317291B1 (enExample)
NZ (1) NZ504503A (enExample)
PT (1) PT1030852E (enExample)
RU (1) RU2215740C2 (enExample)
SK (1) SK284577B6 (enExample)
TR (1) TR200001330T2 (enExample)
WO (1) WO1999024428A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1082323A2 (en) 1998-06-05 2001-03-14 AstraZeneca UK Limited Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
KR100355345B1 (ko) * 2000-01-21 2002-10-12 한국과학기술연구원 티오펜환을 함유한 신규한 옥사졸리디논 유도체, 그의 제조방법 및 조성물
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
MXPA05001558A (es) 2002-08-12 2005-09-08 Pharmacia & Upjohn Co Llc N-aril-2-oxazolidinonas y sus derivados.
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
MXPA06002188A (es) * 2003-08-25 2006-04-27 Warner Lambert Co Nuevos compuestos antimicrobianos de ariloxazolidinona.
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
WO2006056877A2 (en) * 2004-11-29 2006-06-01 Pharmacia & Upjohn Company Llc Diazepine oxazolidinones as antibacterial agents
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
CA2610978A1 (en) 2005-06-29 2007-01-04 Pharmacia & Upjohn Company Llc Homomorpholine oxazolidinones as antibacterial agents
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
WO2007039132A1 (de) 2005-10-04 2007-04-12 Bayer Healthcare Ag Neue polymorphe form und die amorphe form von 5-chlor-n- ( { ( 5s ) -2-0x0-3-[4-( 3-oxo-4-morpholinyl) - phenyl] -1,3-oxazolidin-5-yl} -methyl) -2- thiophencarboxamid
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
CN101460495B (zh) 2006-03-31 2013-08-14 财团法人乙卯研究所 具有杂环的化合物
EP2669283A1 (en) 2007-10-02 2013-12-04 Shionogi&Co., Ltd. Oxazolidinone derivative having 7-membered hetero ring
US20130296569A1 (en) 2010-11-03 2013-11-07 Vijaykumar Jagdishwar Patil Process for the preparation of phosphoric acid mono-(1--4-methoxymethyl-piperidin-4-yl) ester
WO2015173664A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
ATE95176T1 (de) * 1987-10-21 1993-10-15 Du Pont Merck Pharma Aminomethyl-oxo-oxazolidinyl-ethenylbenzenderivate, nuetzlich als antibakterielles mittel.
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
ES2157934T3 (es) * 1988-09-15 2001-09-01 Upjohn Co Fenil-5-beta-amidometiloxazolidin-2-onas sustituidas con nitrogeno en la posicion 3.
EP0610265B1 (en) * 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
NZ274966A (en) * 1993-11-22 1998-01-26 Upjohn Co Substituted-hydroxyacetyl piperazine phenyl oxazolidinone derivatives, use in pharmaceutical compositions
JPH0873455A (ja) * 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
PT1030852E (pt) 2004-02-27
BR9813985A (pt) 2000-09-26
NO20002434L (no) 2000-05-11
CN1271358A (zh) 2000-10-25
KR20010031953A (ko) 2001-04-16
CA2303959A1 (en) 1999-05-20
DE69818294D1 (de) 2003-10-23
ATE250054T1 (de) 2003-10-15
HUP0100470A2 (hu) 2002-05-29
JP2001522849A (ja) 2001-11-20
WO1999024428A1 (en) 1999-05-20
SK6182000A3 (en) 2000-12-11
EP1030852A1 (en) 2000-08-30
EP1030852B1 (en) 2003-09-17
TR200001330T2 (tr) 2000-11-21
NO317291B1 (no) 2004-10-04
RU2215740C2 (ru) 2003-11-10
AU739055B2 (en) 2001-10-04
DK1030852T3 (da) 2003-12-22
NO20002434D0 (no) 2000-05-11
DE69818294T2 (de) 2004-07-08
ES2207010T3 (es) 2004-05-16
SK284577B6 (sk) 2005-07-01
IL136062A (en) 2004-02-08
IL136062A0 (en) 2001-05-20
HK1030373A1 (en) 2001-05-04
CN1154644C (zh) 2004-06-23
HUP0100470A3 (en) 2002-08-28
AU1277899A (en) 1999-05-31
US5998406A (en) 1999-12-07

Similar Documents

Publication Publication Date Title
IL136062A0 (en) Oxazolidinone derivatives and pharmaceutical compositions
GEP20053429B (en) 3-Aminoquinazolin-2,4-Dione, Pharmaceutical Composition Containing Them and Use Thereof as Antibacterial Agents
NZ506058A (en) Antibacterial 9-substituted tetracyclines, and pharmaceuticals and uses thereof
NZ325837A (en) Carbamoyloxy derivatives of mutiline and their use as antibacterials
EG25017A (en) N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobials.
PL316033A1 (en) Acidified nitrite as an agent against micro-organisms
ATE221521T1 (de) Azolylpiperazinylphenyloxazolidinone als antimikrobielle mittel
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
BR9909994A (pt) Quinolinas usadas como inibidores de mrs e bactericidas
PL358666A1 (en) 2-hydroxy-mutilin carbamate derivatives for antibacterial use
DE69723864D1 (en) Ethyliden-derivate tricyclyscher carbapenems
NZ333926A (en) Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
MY128739A (en) Compositions and methods for treating bacterial infections
GR3036873T3 (en) Dialkyltiacumicin compounds
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
AU4540096A (en) Basic oxazoline-amide derivatives of ge 2270 and ge 2270-like antibiotics
ATE161006T1 (de) Alkohole als kaliumchannelöffner und zur behandlung der harnincontinenz
AU5390900A (en) Potassium channel blocking agents
AU6871196A (en) Use of prostane derivatives and the combination thereof with antibiotics in the treatment of bacterial infections
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
BR0308734A (pt) Composto, composição farmacêutica, uso do composto, e, método para prevenir ou tratar infecção
EP0365329A3 (en) Antibiotics active against anaerobic bacteria, their production and use, and strains of enterobacter producing the same
AU5526499A (en) Ingestible compositions comprising antibacterial agents
GEP20033144B (en) Hygromycin A Derivatives as Antibacterial Agents
MX9805962A (es) Pirido (3,2,1-ij)-1,3,4-benzoxadiazina.

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)